Peripheral arterial disease affects approximately 12.5 million people aged 40 and older in the United States, with prevalence rising to 15-20% among adults over 80. The rate of cardiovascular events and death from cardiovascular causes among people with PAD is two to three times higher than among those without, even after adjusting for shared risk factors, and its most severe form, chronic limb-threatening ischemia, carries a historical one-year mortality of 25-35%. Because ICD-10 coding for PAD depends on four distinct axes of specificity, from vessel type to ulcer site, precise documentation is essential to both accurate risk adjustment and timely escalation of care.
AAVBC's Peripheral Arterial Disease Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 I70.2x coding specificity by severity, vessel type, and laterality, HCC 263/264 RAF mapping, ABI and toe-brachial index diagnostic thresholds, Fontaine, Rutherford, and WIfI staging systems, geriatric risk factors and subtle presentations, MEAT documentation standards, and 2024 ACC/AHA-aligned treatment including supervised exercise therapy. Grounded in current ACC/AHA guidance, this guide supports consistent, individualized clinical decision-making, helping care teams recognize atypical presentations, stage severity accurately, and code with the specificity risk adjustment requires, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of peripheral arterial disease — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Peripheral arterial disease affects approximately 12.5 million people aged 40 and older in the United States, with prevalence rising to 15-20% among adults over 80. The rate of cardiovascular events and death from cardiovascular causes among people with PAD is two to three times higher than among those without, even after adjusting for shared risk factors, and its most severe form, chronic limb-threatening ischemia, carries a historical one-year mortality of 25-35%. Because ICD-10 coding for PAD depends on four distinct axes of specificity, from vessel type to ulcer site, precise documentation is essential to both accurate risk adjustment and timely escalation of care.
AAVBC's Peripheral Arterial Disease Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 I70.2x coding specificity by severity, vessel type, and laterality, HCC 263/264 RAF mapping, ABI and toe-brachial index diagnostic thresholds, Fontaine, Rutherford, and WIfI staging systems, geriatric risk factors and subtle presentations, MEAT documentation standards, and 2024 ACC/AHA-aligned treatment including supervised exercise therapy. Grounded in current ACC/AHA guidance, this guide supports consistent, individualized clinical decision-making, helping care teams recognize atypical presentations, stage severity accurately, and code with the specificity risk adjustment requires, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of peripheral arterial disease — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
